NCT02588014 The Neural Bases of Early Visual and Auditory Processing and Emotion Recognition Deficits in Schizophrenia Status UNKNOWN Phase N/A
NCT02576613 Modified Psychodynamic Psychotherapy for Patients With Schizophrenia Status COMPLETED Phase NA
NCT02573168 Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics Status COMPLETED Phase NA
NCT02566057 Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis Status COMPLETED Phase NA
NCT02565524 the Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder. Status COMPLETED Phase NA
NCT02552758 The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism Status UNKNOWN Phase NA
NCT02538445 Can we Forget? Directed Forgetting and Embodied Cognition in Schizophrenia Status COMPLETED Phase NA
NCT02535676 Schizophrenia TreAtment With electRic Transcranial Stimulation Status COMPLETED Phase PHASE3
NCT02534363 Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up Status COMPLETED Phase PHASE4
NCT02533232 Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia Status UNKNOWN Phase PHASE1